{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:16:33Z","timestamp":1775304993488,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.14310\/horm.2002.1526","type":"journal-article","created":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T18:00:13Z","timestamp":1411322413000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"14","author":[{"given":"Djuro","family":"Macut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Bo\u017ei\u0107 Anti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Nestorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladanka","family":"Topalovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelica","family":"Bjeki\u0107 Macut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Kastratovi\u0107 Kotlica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Mati\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Vojnovi\u0107 Milutinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"14010109_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO, 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745\u20132749.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al, 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91: 456\u2013488.","journal-title":"Fertil Steril"},{"issue":"Suppl1","key":"14010109_CR3","first-page":"198","volume":"3","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Papailiou J, Palimeri S, 2006 Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS. Pediatr Endocrinol Rev 3: Suppl 1: 198\u2013204.","journal-title":"Pediatr Endocrinol Rev"},{"key":"14010109_CR4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399408000598","volume":"10","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E, 2008 Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10: e3.","journal-title":"Expert Rev Mol Med"},{"key":"14010109_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","volume":"62","author":"A Kumar","year":"2005","unstructured":"Kumar A, Woods KS, Bartolucci AA, Azziz R, 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62: 644\u2013649.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"14010109_CR6","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1210\/jc.2009-0837","volume":"94","author":"DA Vassiliadi","year":"2009","unstructured":"Vassiliadi DA, Barber TM, Hughes BA, et al, 2009 Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome. J Clin Endocrinol Metab 94: 3558\u20133566.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","volume":"8","author":"BO Yildiz","year":"2007","unstructured":"Yildiz BO, Azziz R, 2007 The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord 8: 331\u2013342.","journal-title":"Rev Endocr Metab Disord"},{"key":"14010109_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000125210","volume":"50","author":"A Ratka","year":"1989","unstructured":"Ratka A, Sutanto W, Bloemers M, de Kloet ER, 1989 On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50: 117\u2013123.","journal-title":"Neuroendocrinology"},{"key":"14010109_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2009.09.002","volume":"75","author":"NC Nicolaides","year":"2010","unstructured":"Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E, 2010 The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75: 1\u201312.","journal-title":"Steroids"},{"key":"14010109_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mce.2008.10.001","volume":"300","author":"KL Gross","year":"2009","unstructured":"Gross KL, Lu NZ, Cidlowski JA, 2009 Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 300: 7\u201316.","journal-title":"Mol Cell Endocrinol"},{"key":"14010109_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1196\/annals.1321.007","volume":"1024","author":"N Ismaili","year":"2004","unstructured":"Ismaili N, Garabedian MJ, 2004 Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 1024: 86\u2013101.","journal-title":"Ann N Y Acad Sci"},{"key":"14010109_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1210\/me.2006-0345","volume":"21","author":"T Kino","year":"2007","unstructured":"Kino T, Ichijo T, Amin ND, et al, 2007 Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21: 1552\u20131568.","journal-title":"Mol Endocrinol"},{"key":"14010109_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/me.2007-0219","volume":"22","author":"W Chen","year":"2008","unstructured":"Chen W, Dang T, Blind RD, et al, 2008 Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 22: 1754\u20131766.","journal-title":"Mol Endocrinol"},{"key":"14010109_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/TCRM.S6864","volume":"4","author":"R Mathur","year":"2008","unstructured":"Mathur R, Levin O, Azziz R, 2008 Use of ethinylestradiol\/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag 4: 487\u2013492.","journal-title":"Ther Clin Risk Manag"},{"key":"14010109_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1055\/s-0031-1283122","volume":"119","author":"D Vojnovi\u0107 Milutinovi\u0107","year":"2011","unstructured":"Vojnovi\u0107 Milutinovi\u0107 D, Macut D, Bo\u017ei\u0107 I, Nestorov J, Damjanovi\u0107 S, Mati\u0107 G, 2011 Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 119: 636\u2013643.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"14010109_CR16","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). 2004 Fertil Steril 81: 19\u201325.","journal-title":"Fertil Steril"},{"key":"14010109_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","volume":"57","author":"JS Laven","year":"2002","unstructured":"Laven JS, Imani B, Eijkemans MJ, Fauser BC, 2002 New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57: 755\u2013767.","journal-title":"Obstet Gynecol Surv"},{"key":"14010109_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD, 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21: 1440\u20131447.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/eje.1.02187","volume":"155","author":"D Macut","year":"2006","unstructured":"Macut D, Damjanovi\u0107 S, Panidis D, et al, 2006 Oxidised low-density lipoprotein concentration \u2014 early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 155: 131\u2013136.","journal-title":"Eur J Endocrinol"},{"key":"14010109_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1521-6934(02)00119-0","volume":"17","author":"A Balen","year":"2003","unstructured":"Balen A, Rajkowha M, 2003 Polycystic ovary syndrome\u2014a systemic disorder? Best Pract Res Clin Obstet Gynaecol 17: 263\u2013274.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"14010109_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0015-0282(16)45254-4","volume":"35","author":"RS Mathur","year":"1981","unstructured":"Mathur RS, Moody LO, Landgrebe S, Williamson HO, 1981 Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril 35: 29\u201335.","journal-title":"Fertil Steril"},{"key":"14010109_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"14010109_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0003-2697(78)90327-5","volume":"86","author":"T Spector","year":"1978","unstructured":"Spector T, 1978 Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 86: 142\u2013146.","journal-title":"Anal Biochem"},{"key":"14010109_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2265.2012.04415.x","volume":"78","author":"N Cinar","year":"2013","unstructured":"Cinar N, Harmanci A, Bayraktar M, Yildiz BO, 2013 Ethinyl estradiol-drospirenone vs ethinyl estradioldrospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 78: 379\u2013384.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"14010109_CR25","first-page":"269","volume":"19","author":"ER De Kloet","year":"1998","unstructured":"De Kloet ER, Vreugdenhil E, Oitzl MS, Jo\u00ebls M, 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269\u2013301.","journal-title":"Endocr Rev"},{"key":"14010109_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000321235","volume":"20","author":"RH DeRijk","year":"2010","unstructured":"DeRijk RH, de Kloet ER, Zitman FG, van Leeuwen N, 2010 Mineralocorticoid receptor gene variants as determinants of HPA axis regulation and behavior. Endocr Dev 20: 137\u2013148.","journal-title":"Endocr Dev"},{"key":"14010109_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0076-6879(95)51144-X","volume":"251","author":"SS Simons Jr","year":"1995","unstructured":"Simons SS Jr, Pratt WB, 1995 Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol 251: 406\u2013422.","journal-title":"Methods Enzymol"},{"key":"14010109_CR28","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2003-031158","volume":"89","author":"M Guido","year":"2004","unstructured":"Guido M, Romualdi D, Giuliani M, et al, 2004 Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab 89: 2817\u20132823.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.contraception.2012.06.003","volume":"87","author":"CL Westhoff","year":"2013","unstructured":"Westhoff CL, Petrie KA, Cremers S, 2013 Using changes in binding globulins to assess oral contraceptive compliance. Contraception 87: 176\u2013181.","journal-title":"Contraception"},{"key":"14010109_CR30","first-page":"883","volume":"159","author":"MJ Weiser","year":"2009","unstructured":"Weiser MJ, Handa RJ, 2009 Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuro science 159: 883\u2013895.","journal-title":"Neuro science"},{"key":"14010109_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","volume":"68","author":"W Elger","year":"2003","unstructured":"Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A, 2003 Conception and pharmacodynamic profile of drospirenone. Steroids 68: 891\u2013905.","journal-title":"Steroids"},{"key":"14010109_CR32","first-page":"3176","volume":"86","author":"E Arvat","year":"2001","unstructured":"Arvat E, Maccagno B, Giordano R, et al, 2001 Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J Clin Endocrinol Metab 86: 3176\u20133181.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR33","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1210\/jc.2004-0086","volume":"89","author":"P Wellhoener","year":"2004","unstructured":"Wellhoener P, Born J, Fehm HL, Dodt C, 2004 Elevated resting and exercise-induced Cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J Clin Endocrinol Metab 89: 5048\u20135052.","journal-title":"J Clin Endocrinol Metab"},{"key":"14010109_CR34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1210\/edrv-10-3-232","volume":"10","author":"CM Mendel","year":"1989","unstructured":"Mendel CM, 1989 The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10: 232\u2013274.","journal-title":"Endocr Rev"},{"key":"14010109_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0306-4530(00)00006-8","volume":"25","author":"I Heuser","year":"2000","unstructured":"Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F, 2000 Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25: 513\u2013518.","journal-title":"Psychoneuroendocrinology"},{"key":"14010109_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/eje.0.1510397","volume":"151","author":"C Grossmann","year":"2004","unstructured":"Grossmann C, Scholz T, Rochel M, et al, 2004 Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 151: 397\u2013406.","journal-title":"Eur J Endocrinol"},{"key":"14010109_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.psyneuen.2009.07.006","volume":"35","author":"N van Leeuwen","year":"2010","unstructured":"van Leeuwen N, Kumsta R, Entringer S, et al, 2010 Functional mineralocorticoid receptor (MR) gene variation influences the Cortisol awakening response after dexamethasone. Psychoneuroendocrinology 35: 339\u2013349.","journal-title":"Psychoneuroendocrinology"},{"key":"14010109_CR38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1530\/EJE-09-1076","volume":"162","author":"R Berardelli","year":"2010","unstructured":"Berardelli R, Karamouzis I, Marinazzo E, et al, 2010 Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. Eur J Endocrinol 162: 1067\u20131074.","journal-title":"Eur J Endocrinol"},{"key":"14010109_CR39","doi-asserted-by":"publisher","first-page":"169 e1","DOI":"10.1016\/j.ajog.2009.09.038","volume":"202","author":"F Mancini","year":"2010","unstructured":"Mancini F, Cianciosi A, Persico N, Facchinetti F, Busacchi P, Battaglia C, 2010 Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study. Am J Obstet Gynecol 202: 169 e1\u20138.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1526\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:37:51Z","timestamp":1739115471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["14010109"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1526","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"28 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}